A comprehensive model of predictors of quality of life in older adults with schizophrenia: results from the CSA study.
Details
Serval ID
serval:BIB_CABF88B0087C
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
A comprehensive model of predictors of quality of life in older adults with schizophrenia: results from the CSA study.
Journal
Social psychiatry and psychiatric epidemiology
Working group(s)
CSA Study group
Contributor(s)
Adès J., Alezrah C., Amado I., Amar G., Andréi O., Arbault D., Archambault G., Aurifeuille G., Barrière S., Béra-Potelle C., Blumenstock Y., Bardou H., Bareil-Guérin M., Barrau P., Barrouillet C., Baup E., Bazin N., Beaufils B., Ben Ayed J., Benoit M., Benyacoub K., Bichet T., Blanadet F., Blanc O., Blanc-Comiti J., Boussiron D., Bouysse A.M., Brochard A., Brochart O., Bucheron B., Cabot M., Chabannes J.M., Charpeaud T., Clad-Mor C., Combes C., Comisu M., Cordier B., Cormier L., Costi F., Courcelles J.P., Creixell M., Cuche H., Cuervo-Lombard C., Dammak A., Da Rin D., Denis J.B., Denizot H., Deperthuis A., Diers E., Dirami S., Donneau D., Dreano P., Duprat E., Duthoit D., Fernandez C., Fonfrede P., Freitas N., Gasnier P., Gauillard J., Getten F., Gierski F., Godart F., Gourevitch R., Grassin Delyle A., Gremion J., Griner V., Guerin-Langlois C., Guggiari C., Guillin O., Hadaoui H., Haffen E., Hanon C., Haouzir S., Hazif-Thomas C., Heron A., Hubsch B., Jalenques I., Januel D., Kaladjian A., Karnycheff J.F., Kebir O., Krebs M.O., Lajugie C., Leboyer M., Legrand P., Lejoyeux M., Lemaire V., Leroy E., Levy-Chavagnat D., Leydier A., Liling C., Llorca P.M., Loeffel P., Louville P., Lucas Navarro S., Mages N., Mahi M., Maillet O., Manetti A., Martelli C., Martin P., Masson M., Maurs-Ferrer I., Mauvieux J., Mazmanian S., Mechin E., Mekaoui L., Meniai M., Metton A., Mihoubi A., Miron M., Mora G., Niro Adès V., Nubukpo P., Omnes C., Papin S., Paris P., Passerieux C., Pellerin J., Perlbarg J., Perron S., Petit A., Petitjean F., Portefaix C., Pringuey D., Radtchenko A., Rahiou H., Raucher-Chéné D., Rauzy A., Reinheimer L., Renard M., René M., Rengade C.E., Reynaud P., Robin D., Rodrigues C., Rollet A., Rondepierre F., Rousselot B., Rubingher S., Saba G., Salvarelli J.P., Samuelian J.C., Sánchez Rico M., Scemama-Ammar C., Schuster J.P., Sechter D., Segalas B., Seguret T., Seigneurie A.S., Semmak A., Slama F., Taisne S., Taleb M., Terra J.L., Thefenne D., Tran E., Tourtauchaux R., Vacheron M.N., Vanhoucke V., Venet E., Verdoux H., Viala A., Vidon G., Vitre M., Vurpas J.L., Wagermez C., Walter M., Yon L., Zendjidjian X.
ISSN
1433-9285 (Electronic)
ISSN-L
0933-7954
Publication state
Published
Issued date
08/2021
Peer-reviewed
Oui
Volume
56
Number
8
Pages
1411-1425
Language
english
Notes
Publication types: Journal Article ; Multicenter Study
Publication Status: ppublish
Publication Status: ppublish
Abstract
Numerous factors are known to influence quality of life of adults with schizophrenia. However, little is known regarding the potential predictors of quality of life in the increasing population of older adults with schizophrenia. The main objective of the present study was to propose a comprehensive model of quality of life in this specific population.
Data were derived from the Cohort of individuals with Schizophrenia Aged 55 years or more (CSA) study, a large (N = 353) multicenter sample of older adults with schizophrenia or schizoaffective disorder recruited from French community mental-health teams. We used structural equation modeling to simultaneously examine the effects of six broad groups of clinical factors previously identified as potential predictors of quality of life in this population, including (1) severity of general psychopathology, (2) severity of depression, (3) severity of cognitive impairment, (4) psychotropic medications, (5) general medical conditions and (6) sociodemographic characteristics.
General psychopathology symptoms, and in particular negative and depressive symptoms, cognitive impairment, reduced overall functioning and low education were significantly and independently associated with diminished quality of life (all p < 0.05). Greater number of medical conditions and greater number of antipsychotics were also independently and negatively associated with quality of life, although these associations did not reach statistical significance in sensitivity analyses, possibly due to limited statistical power.
Several domains are implicated in quality of life among older adults with schizophrenia. Interventions targeting these factors may help improve importantly quality of life of this vulnerable population.
Data were derived from the Cohort of individuals with Schizophrenia Aged 55 years or more (CSA) study, a large (N = 353) multicenter sample of older adults with schizophrenia or schizoaffective disorder recruited from French community mental-health teams. We used structural equation modeling to simultaneously examine the effects of six broad groups of clinical factors previously identified as potential predictors of quality of life in this population, including (1) severity of general psychopathology, (2) severity of depression, (3) severity of cognitive impairment, (4) psychotropic medications, (5) general medical conditions and (6) sociodemographic characteristics.
General psychopathology symptoms, and in particular negative and depressive symptoms, cognitive impairment, reduced overall functioning and low education were significantly and independently associated with diminished quality of life (all p < 0.05). Greater number of medical conditions and greater number of antipsychotics were also independently and negatively associated with quality of life, although these associations did not reach statistical significance in sensitivity analyses, possibly due to limited statistical power.
Several domains are implicated in quality of life among older adults with schizophrenia. Interventions targeting these factors may help improve importantly quality of life of this vulnerable population.
Keywords
Aged, Antipsychotic Agents/therapeutic use, Cognitive Dysfunction, Humans, Psychotic Disorders/drug therapy, Quality of Life, Schizophrenia/drug therapy, Schizophrenia/epidemiology, Antipsychotics, Cognition, Comprehensive model, Depression, Elderly, Late-life, Older, Quality of life, Schizophrenia, Structural equation modeling, Symptoms
Pubmed
Web of science
Create date
05/05/2023 16:59
Last modification date
13/05/2023 6:51
Usage data
